Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

NCT00122538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infections
AIDS

Interventions

DRUG: Efavirenz (EFV)
DRUG: Lamivudine (3TC)
DRUG: Didanosine (ddI)

Sponsor

French National Agency for Research on AIDS and Viral Hepatitis